ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacDonald, A
Right arrow Articles by Booth, I W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacDonald, A
Right arrow Articles by Booth, I W
Arch Dis Child 1998;78:122-126 ( February )

Does a single plasma phenylalanine predict quality of control in phenylketonuria?

A MacDonald,a G W Rylance,a D Asplin,a S K Hall,a I W Boothb

a Children's Hospital, Birmingham, b University of Birmingham, Institute of Child Health, Birmingham

Correspondence to: Mrs A MacDonald, Dietetic Services, Children's Hospital, Ladywood Middleway, Birmingham B16 8ET.


Accepted 26 September 1997

A 1993 MRC working group on phenylketonuria suggested standardising blood phenylalanine measurements by taking blood samples at the same time each day. Since it is not known how representative of a 24 hour period a single phenylalanine concentration is, the aim of this study was to investigate the 24 hour variability of plasma phenylalanine in well controlled children with phenylketonuria. Sixteen subjects, 12 girls and four boys aged 1 to 18 years, had hourly venous blood samples collected for 13 hours between 09.00 and 21.00 on one day. Serial skin puncture blood specimens were then collected at 24.00, 03.00, and 06.00 within the same 24 hour period. All food and drink was weighed. The median variation in plasma phenylalanine concentration was 155 µmol/l/day, with a minimum of 80 and a maximum of 280. The highest concentration occurred in the morning between 6.00 and 9.00 in 63% of subjects; the lowest occurred between midday and midnight in 94%. Concentrations < 100 µmol/l occurred in 46% of children below 11 years, three having concentrations < 30 µmol/l for two, six, and seven hours respectively. Three of five subjects had concentrations above the MRC guidelines for 24% of the period studied. Except in two subjects, the blood concentrations did not rise in response to phenylalanine consumption. However, the greater the quantity of protein substitute taken between waking and the 16.00 specimen, the larger the decrease in daytime phenylalanine concentration (r = -0.7030) (p < 0.005). There is therefore wide variability in phenylalanine concentrations in a 24 hour period in children with phenylketonuria which is not reflected in a single observation. Further study is needed to investigate the effects of timing of protein substitute on the stability of phenylalanine concentrations.

Keywords: phenylketonuria; plasma phenylalanine; phenylalanine


© 1998 by Archives of Disease in Childhood



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. N. Sarkissian, A. Gamez, L. Wang, M. Charbonneau, P. Fitzpatrick, J. F. Lemontt, B. Zhao, M. Vellard, S. M. Bell, C. Henschell, et al.
Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria
PNAS, December 30, 2008; 105(52): 20894 - 20899.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
F. Maillot, M. Lilburn, J. Baudin, D. W Morley, and P. J Lee
Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine
Am. J. Clinical Nutrition, September 1, 2008; 88(3): 700 - 705.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
A MacDonald, A Chakrapani, C Hendriksz, A Daly, P Davies, D Asplin, K Hall, and I W Booth
Protein substitute dosage in PKU: how much do young patients need?
Arch. Dis. Child., July 1, 2006; 91(7): 588 - 593.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
P J Lee, D Ridout, J H Walter, and F Cockburn
Maternal phenylketonuria: report from the United Kingdom Registry 1978-97
Arch. Dis. Child., February 1, 2005; 90(2): 143 - 146.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
A MacDonald, C Ferguson, G Rylance, A A M Morris, D Asplin, S K Hall, and I W Booth
Are tablets a practical source of protein substitute in phenylketonuria?
Arch. Dis. Child., April 1, 2003; 88(4): 327 - 329.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
F. J van Spronsen, M. van Rijn, J. Bekhof, R. Koch, and P. G. Smit
Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets
Am. J. Clinical Nutrition, February 1, 2001; 73(2): 153 - 157.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
K. Widhalm
Protein Status of Infants with Phenylketonuria Undergoing Therapy
J. Am. Coll. Nutr., April 1, 1999; 18(2): 99 - 99.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1998 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health